References
- Aslanian V., Lemaignen H., Bonoof P., Svaland M., Børseth A., Lundby B. Evaluation of the clinical safety of gadodiamide injection (Omniscan), a new non-ionic MR contrast agent for the central nervous system. A European perspective. Neuroradiology 1995
- Baleriaux D., Matos C., de Greef D. Gadodiamide injection as a contrast medium for MRI of the central nervous system. A comparison with gadolinium-DOTA. Neuro-radiology 1993; 35: 490
- Brugières P., Gaston A., Degryse H. R., et al. Randomized double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA). Neuro-radiology 1994; 36: 27
- Myhr G., Rinck P. A., Børseth A. Gadodiamide injection and gadopentetate dimeglumine. A double blind study in MR imaging of the CNS. Acta Radiol. 1992; 33: 405
- 1994, Nycomed Imaging A/S, Oslo, Norway, Personal communication
- Sze G., Brant-Zawadzki M., Haughton V. M., et al. Multi-center study of gadodiamide injection as a contrast agent in MR imaging of the brain and spine. Radiology 1991; 181: 693
- Valk J., Algra P. R., Hazenberg C. J., Slooff W. B. M., Svaland M. G. A double blind, comparative study of gadodiamide injection and gadopentetate dimeglumine in MR examinations of the central nervous system. Neuro-radiology 1993; 35: 173